Andrew J. Last insider trades
Open-market stock purchases and sales by Andrew J. Last, Director at Insight Molecular Diagnostics Inc, from SEC Form 4 filings since Aug 19, 2010.
Track record: 100% of 2 scored buys are up 5% or more since purchase, averaging +137%.
Companies traded
- IMDX Insight Molecular Diagnostics Inc: other filings, last Jul 1, 2026
- BIO BIOB Bio-Rad Laboratories, Inc: 4 sales, last Sep 6, 2024
- OCX Oncocyte Corp: 2 buys, last Jul 1, 2024
- BIO, BIOB Bio-Rad Laboratories, Inc: other filings, last Sep 2, 2020
- BIO,BIOB Bio-Rad Laboratories, Inc: other filings, last Apr 29, 2020
- XON Intrexon Corp: 2 buys, last Nov 13, 2017
- AFFX Affymetrix Inc: 3 buys, 1 sale, last Mar 31, 2016